To evaluate the value of myosonography in inflammatory myopathies ultr
asound of skeletal muscles was performed in 70 patients, aged 21-82 ye
ars, suffering from histologically proven polymyositis (n = 30), derma
tomyositis (n = 18), granulomatous myositis (n = 9), inclusion body my
ositis (n = 13), and in 102 control persons. The sensitivity of muscle
ultrasound in detecting histopathologically proven disease (82.9%) wa
s not significantly different from electromyography (92.4%) or serum c
reatine kinase activity (68.7%). The positive predictive value of ultr
asound was 95.1%, the negative predictive value 89.2%, and the accurac
y 91.3%. The different types of inflammatory myopathies presented with
typical, but not specific ultrasound features. Polymyositis showed at
rophy and increased echointensity predominantly of lower extremity mus
cles, whereas in dermatomyositis clear muscle atrophy was rare and ech
ointensities were highest in forearm muscles. Echointensities were low
er in dermatomyositis compared to poly- and granulomatous myositis. Gr
anulomatous myositis was characterized by the highest echointensities
and a tendency towards muscle hypertrophy. Severe muscle atrophy was t
he most impressive feature in the majority of patients with inclusion
body myositis. Comparison of ultrasound and histopathological findings
indicates that muscle lipomatosis has a much greater impact on muscul
ar echointensity than does muscle fibrosis. Ultrasound of myositis imp
roved clinical assessment of patients by supplying differential diagno
stic clues based on precise muscle size measurements and identificatio
n of mesenchymal abnormalities, particularly muscle lipomatosis.